Clear view on diquafosol

Inspire Pharmaceuticals Inc. is not overly concerned about the failure of its 2% diquafosol tetrasodium drops in treating dry eye in a controlled adverse environment (CAE) chamber. The company says that the success of INS365 in reducing

Read the full 373 word article

How to gain access

Continue reading with a
two-week free trial.